Company news: Bristol-Myers Squibb, Corcept Therapeutics, Vivus, Orexigen and Arena
Bristol-Myers Squibb continues to come under scrutiny for how it has marketed its anti-psychotic drug Abilify (aripiprazole).
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.